Two Sigma Advisers’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-122,700
Closed -$1.32M 2840
2021
Q3
$1.32M Sell
122,700
-194,100
-61% -$1.77M ﹤0.01% 1482
2021
Q2
$2.89M Buy
316,800
+260,200
+460% +$2.41M 0.01% 1122
2021
Q1
$534K Buy
+56,600
New +$779K ﹤0.01% 1998
2020
Q4
Sell
-43,000
Closed -$114K 2641
2020
Q3
$114K Buy
43,000
+15,900
+59% +$59K ﹤0.01% 2255
2020
Q2
$180K Buy
+27,100
New +$183K ﹤0.01% 2272

Other funds holding GRTS

Two Sigma Advisers's GRTS Position: Q4 2021 in Review

Two Sigma Advisers sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2021, closing a stake of 122,700 shares — an estimated $1.32M sold.

Two Sigma Advisers first reported a position in GRTS in Q2 2020 and held it in 5 quarters. The position peaked at $2.89M in Q2 2021. 115 funds tracked by Wall St. Rank hold GRTS as of Q4 2021.

  • Two Sigma Advisers reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Two Sigma Advisers sold 122,700 Gritstone bio, Inc. Common Stock shares in Q4 2021, an estimated $1.32M.
  • Two Sigma Advisers first reported a position in Gritstone bio, Inc. Common Stock in Q2 2020 and held it in 5 quarters.
  • Two Sigma Advisers's Gritstone bio, Inc. Common Stock position peaked at $2.89M in Q2 2021.
  • 115 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2021.

Based on Two Sigma Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.